QIAGEN is the leading provider of sample and assay technologies. Sample technologies are used to isolate DNA, RNA, and proteins from any biological sample. Assay technologies are then used to make specific target biomolecules, such as the DNA of a specific virus, visible for subsequent analysis. The firm has developed and market more than 1500 consumable products and automated solutions. Portfolio includes the FDA-approved and CE-marked digene HPV Test, which is regarded as the gold standard in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer. Products are sold to molecular diagnostics laboratories, academic research markets, leading pharmaceutical and biotechnology companies, as well as to customers in applied testing markets such as forensics, animal or food testing, and pharmaceutical process control.